E. Cozzi et al., Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts, TRANSPLANT, 70(1), 2000, pp. 15-21
Background. Recently, there has been a resumed interest in clinical xenotra
nsplantation using pig organs, However, no data are available yet regarding
the capacity of porcine organs to sustain the life of a primate beyond the
first month, We have attempted to obtain long-term survival of nonhuman pr
imates using human decay-accelerating factor (hDAF) transgenic pig organs a
nd an immunosuppressive strategy particularly aimed at neutralizing the hum
oral component of the immune response.
Methods, hDAF transgenic or control kidneys were transplanted into 14 bilat
erally nephrectomized cynomolgus monkeys (Macaca fascicularis) that underwe
nt splenectomy and mere immunosuppressed with cyclosporine A, cyclophospham
ide, and steroids, All animals also received recombinant erythropoietin, Po
stoperatively, the primates were monitored daily. Laboratory evaluations in
cluded serum biochemistry, hematology, and measurements of hemolytic antipi
g antibodies. To assess the role of splenectomy in the control of humoral r
esponse, historical data were also used from a group of monkeys (n=7) that
received the same immunosuppressive regimen and an hDAF transgenic porcine
kidney but did not have splenectomy or receive recombinant erythropoietin,
Results, This immunosuppressive approach obtained the longest survival time
(78 days) described to date of a primate receiving a life-supporting porci
ne renal xenograft, Furthermore, four of nine animals in this series surviv
ed for 50 days or more. Most biochemical measurements in this study (includ
ing plasma urea, creatinine, sodium, and potassium concentrations) remained
within normal ranges for several weeks in all of the longest-surviving ani
mals.
Conclusions. Normalization of renal function (urea and creatinine) in prima
te recipients of porcine renal xenografts suggests that pig kidneys may be
suitable for future clinical xenotransplantation. Additional immunosuppress
ive approaches, specifically designed to prevent humorally mediated immunol
ogical damage, should be explored to further prolong survival of primates t
hat have received porcine xenografts.